Abstract:The heart has an abundance of mitochondria since cardiac muscles require copious amounts of energy for providing continuous blood through the circulatory system, thereby implying that myocardial function is largely reliant on mitochondrial energy. Thus, cardiomyocytes are susceptible to mitochondrial dysfunction and are likely targets of mitochondrial toxic drugs. Various methods have been developed to evaluate mitochondrial toxicity by evaluating toxicological mechanisms, but an optimized and standardized assay for cardiomyocytes remains unmet. We have therefore attempted to standardize the evaluation system for determining cardiac mitochondrial toxicity, using AC16 human and H9C2 rat cardiomyocytes. Three clinically administered drugs (acetaminophen, amiodarone, and valproic acid) and two anticancer drugs (doxorubicin and tamoxifen) which are reported to have mitochondrial effects, were applied in this study. The oxygen consumption rate (OCR), which directly reflects mitochondrial function, and changes in mRNA levels of mitochondrial respiratory complex I to complex V, were analyzed. Our results reveal that exposure to all five drugs results in a concentration-dependent decrease in the basal and maximal levels of OCR in AC16 cells and H9C2 cells. In particular, marked reduction in the OCR was observed after treatment with doxorubicin. The reduction in OCR after exposure to mitochondrial toxic drugs was found to be associated with reduced mRNA expression in the mitochondrial respiratory complexes, suggesting that the cardiac mitochondrial toxicity of drugs is majorly due to dysfunction of mitochondrial respiration. Based on the results of this study, we established and standardized a protocol to measure OCR in cardiomyocytes. We expect that this standardized evaluation system for mitochondrial toxicity can be applied as basic data for establishing a screening platform to evaluate cardiac mitochondrial toxicity of drugs, during the developmental stage of new drug discovery.

Assessment of Fatty Acid Beta Oxidation in Cells and Isolated Mitochondria

Measurement of Fatty Acid Oxidation by High-Resolution Respirometry: Special Considerations for Analysis of Skeletal and Cardiac Muscle and Adipose Tissue

Impaired fatty acid oxidation as a cause for lipotoxicity in cardiomyocytes

The utility of HepG2 cells to identify direct mitochondrial dysfunction in the absence of cell death

Assessing mitochondrial dysfunction in cells

Dynamic Modelling of an ACADS Genotype in Fatty Acid Oxidation – Application of Cellular Models for the Analysis of Common Genetic Variants

Lipid-droplet associated mitochondria promote fatty-acid oxidation through a distinct bioenergetic pattern in male Wistar rats

Measuring interference of drug-like molecules with the respiratory chain: toward the early identification of mitochondrial uncouplers in lead finding

Establishment of a platform for measuring mitochondrial oxygen consumption rate for cardiac mitochondrial toxicity

Assessment of an automated in vitro basal cytotoxicity test system based on metabolically-competent cells

Basal re-esterification finetunes mitochondrial fatty acid utilization

Impact of metabolic stress induced by diets, aging and fasting on tissue oxygen consumption

Fatty acid β-oxidation in brain mitochondria: Insights from high-resolution respirometry in mouse, rat and Drosophila brain, ischemia and aging models

Risk Assessment of Psychotropic Drugs on Mitochondrial Function Using In Vitro Assays

High-resolution respirometry reveals altered mammalian tissue ketone body oxidation in different cardiometabolic diseases

Mitochondrial Fatty Acid Oxidation Disorders: Laboratory Diagnosis, Pathogenesis, and the Complicated Route to Treatment

Fatty acid-induced mitochondrial uncoupling in adipocytes is not a promising target for treatment of insulin resistance unless adipocyte oxidative capacity is increased

Increased nitroxidative stress promotes mitochondrial dysfunction in alcoholic and nonalcoholic fatty liver disease

A practical and robust method to evaluate metabolic fluxes in primary pancreatic islets

Role of Fatty Acids β-Oxidation in the Metabolic Interactions Between Organs

In Vivo Assessment of Mitochondrial Function